Investors who speak the language of health.
Founded in Paris, TECHLIFE CAPITAL provides growth equity to profitable or near-profitable companies in pharmaceuticals, medical devices, healthcare software and health data.
Meet the teamBorn from the lab, the clinic and the boardroom.
Our partners have spent their careers inside pharmaceutical groups, MedTech scale-ups, hospitals and investment firms. We created TECHLIFE CAPITAL because promising health companies too often stall between venture funding and large buyout capital.
We fill that gap with growth equity tailored to the specific rhythms of healthcare: regulatory approvals, clinical evidence, procurement cycles and reimbursement decisions.
Scaling the companies that improve patient outcomes.
We invest where capital and expertise can measurably accelerate access to better treatments, safer devices and smarter use of health data.
- Patient impact is assessed alongside financial returns
- Strong ethics around clinical evidence and data privacy
- Sustainable growth over short-term multiples
Rooted in Paris, active across Europe.
From our office in the 8th arrondissement, we work with companies in France and throughout Europe, and we support portfolio companies expanding into North America and other international markets.
Visit our officeWhat guides every decision.
Clarity
Transparent terms, honest feedback and decisions explained with care.
Partnership
We earn trust by showing up, listening and delivering on what we promise.
Rigour
Evidence-based diligence on science, regulation, markets and teams.
A team blending investment and healthcare operations.
Investment Partners
Deal leadershipLead origination, structuring and board representation, with backgrounds in growth equity and corporate finance.
Operating Partners
Value creationFormer executives from pharma, MedTech and health IT who work hands-on with management teams.
Advisory Board
Clinical & regulatoryClinicians, regulatory specialists and data-protection experts supporting diligence and portfolio strategy.
Building the next chapter of your healthcare company?
Share your project with our investment team. We reply to every qualified enquiry within five business days.